CompletedNCT00607789
Duloxetine or placebo for binge eating with depression
About this title
Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression
Read the official source — NCT00607789Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateOctober 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- University of Cincinnati
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00607789
- Official title
Show the full official title
A 12-Week, Double-Blind, Placebo-Controlled, Trial of Duloxetine Versus Placebo in the Treatment of Binge Eating Disorder and Comorbid Depressive Disorder.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cincinnati, a university.
Did this study involve medication?
Yes. The study involved medication, including Duloxetine and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
